Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cell Senescence”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT03888534
What this trial is testing

Intravenous Ixazomib in Pediatric Participants With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LLy)

Who this might be right for
Precursor Cell Lymphoblastic Leukemia-lymphoma
Millennium Pharmaceuticals, Inc.
Post-approval studies (Phase 4)Study completedNCT00198978
What this trial is testing

German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Who this might be right for
Adult Acute Lymphocytic Leukemia
Goethe University 377
Testing effectiveness (Phase 2)Study completedNCT00334074
What this trial is testing

Clofarabine and Ara-C for the Treatment of Relapsed AML and Untreated MDS

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic SyndromesChronic Myelogenous Leukemia
Baylor Research Institute 30
Not applicableLooking for participantsNCT07586735
What this trial is testing

A Novel Conditioning Regimen for Haplo-HSCT in Older Patients With SAA

Who this might be right for
Severe Aplastic AnemiaAplastic AnaemiaHematopoietic Cell Transplant
Peking University People's Hospital 64
Not applicableActive Not RecruitingNCT06539468
What this trial is testing

Active Surveillance for the Treatment of Low-Risk Basal Cell Carcinoma in Elderly Patients

Who this might be right for
Skin Basal Cell Carcinoma
University of Michigan Rogel Cancer Center 81
Testing effectiveness (Phase 2)Study completedNCT04113226
What this trial is testing

Assessment of Survival and Autonomy With Rituximab Plus Chemotherapy or Rituximab Plus Lenalidomide for Elderly Patients With Relapsed Diffuse Large B-cell Lymphoma

Who this might be right for
ChemotherapyDiffuse Large B-Cell Lymphoma (DLBCL), NosElderly
Centre Hospitalier Universitaire, Amiens 1
Testing effectiveness (Phase 2)UnknownNCT06066255
What this trial is testing

PROPHYLAXIS OF GVH IN ELDERLY PATIENTS RECEIVING HAPLOIDENTICAL ALLOGENIC HEMATOPOIETIC STEM CELL TRASNPLANTATION USE OF A LOW DOSE ANTI-LYMPHOCYTIC SERUM

Who this might be right for
Hematological Malignancy
Institut Paoli-Calmettes 27
Early research (Phase 1)Active Not RecruitingNCT05636436
What this trial is testing

Safety and Immunogenicity of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 18 Years and Above

Who this might be right for
Herpes Zoster
MAXVAX Biotechnology Limited Liability Company 132
Not applicableStudy completedNCT01536808
What this trial is testing

Premature Aging and Type 2 Diabetes Mellitus: an Increased Risk of Cardiomyopathy?

Who this might be right for
Type 2 Diabetes Mellitus
Hospices Civils de Lyon 150
Large-scale testing (Phase 3)UnknownNCT03530085
What this trial is testing

Dec+Flu+Bu Conditioning Regimen for Elderly AML in CR Undergoing Allo-HSCT

Who this might be right for
Acute Myeloid LeukemiaAllogeneic Hematopoietic Stem Cell TransplantationConditioning+1 more
Nanfang Hospital, Southern Medical University 60
Not applicableStudy completedNCT05574985
What this trial is testing

Recombinant Omicron-Delta COVID-19 Vaccine (CHO Cell)

Who this might be right for
COVID-19
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 272
Not applicableStudy completedNCT03368261
What this trial is testing

Epidemiology and Pathophysiological Mechanisms of HTAP in SS and SC Children in Martinique and Guadeloupe.

Who this might be right for
Sickle Cell Disease
Centre Hospitalier Universitaire de la Guadeloupe 185
Large-scale testing (Phase 3)Ended earlyNCT00286169
What this trial is testing

Amrubicin Study for Elderly Patients With Extensive-disease Small-cell Lung Cancer (ED-SCLC)

Who this might be right for
Small-cell Lung Cancer
Sumitomo Pharma Co., Ltd. 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT04761770
What this trial is testing

Study of a Geriatric Assessment to Plan a Treatment Approach for Older People With Various Blood Disorders

Who this might be right for
Myelodysplastic SyndromeMyeloproliferative NeoplasmsChronic Myelomonocytic Leukemia+2 more
Memorial Sloan Kettering Cancer Center 33
Large-scale testing (Phase 3)Study completedNCT01478542
What this trial is testing

OPTIMAL>60 / DR. CHOP, Improvement of Therapy of Elderly Patients with CD20+ DLBCL Using Rituximab Optimized and Liposomal Vincristine

Who this might be right for
CD20+ Aggressive B-Cell Lymphoma
Universität des Saarlandes 1,152
Testing effectiveness (Phase 2)Study completedNCT00030407
What this trial is testing

Celecoxib and Docetaxel in Treating Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Barbara Ann Karmanos Cancer Institute 34
Early research (Phase 1)Study completedNCT00008177
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+14 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)UnknownNCT01980472
What this trial is testing

Chemotherapy Plus Bevacizumab in Elderly Non-small Cell Lung Cancer Patients

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Grupo de Investigación y Divulgación Oncológica 50
Testing effectiveness (Phase 2)Study completedNCT00802464
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years

Who this might be right for
Herpes Zoster
GlaxoSmithKline 410
Large-scale testing (Phase 3)UnknownNCT05664932
What this trial is testing

Immunogenicity and Safety of COVID-19 Vaccine as a Booster Vaccination in Population Aged 18 Years and Above

Who this might be right for
COVID-19
Guangzhou Patronus Biotech Co., Ltd. 1,200
Next Page
79